Patients with Trisomy 21 (Down syndrome) are at increased risk for anesthesia-related complications, including severe bradycardia and cardiac arrest during anesthesia induction with sevoflurane.[1-4]
Individuals with Down syndrome may experience airway obstruction and have a higher incidence of perioperative respiratory adverse events compared to matched controls.[5-6]
There is an increased risk of severe bradycardia and cardiac arrest not related to congenital heart disease during anesthesia induction with sevoflurane; heart rate should be closely monitored, and adjustments in sevoflurane concentration or administration of anticholinergic or epinephrine may be necessary.[1-4]
Atlantoaxial instability is common in Down syndrome, necessitating cervical spine stability assessment before anesthesia to prevent potential neurological complications.[7-8]
Anesthetic agents like sevoflurane have been associated with increased serum potassium concentrations leading to cardiac arrhythmias, particularly in the presence of neuromuscular disease.[1]